ATH alterity therapeutics limited

11.1%

1.0¢

Ann: Trading Halt, page-168

First 168 Last

Share
Profile

Follow
FiveCent

1,221 Posts.

254

07/02/25

10:05

Post #: 77748793
Share

Originally posted by Mateo335: ↑

After sleeping on it, here are my thoughts on where we are FWIW (not much)

as I said earlier, I think the efficacy and safety profile of this trial have already priced mid pharma out.

Any mid pharma would perhaps offer a up front with royalties and milestones. Suppose they too offered $40M. the catch is they would want total control of the asset and to add it to their pipeline. We would become a minor interest partner in the deal. We would have same money with 0 control over 434.

the most beneficial outcome of a deal would be a total takeover with a B in the price. Clearly a deal is not possible at this stage.

Go it alone is likely to be in our best interest imo. The team has a clear vision on how future trials should be run if needed and we avoid becoming a shell with money that is waiting on another pharma to get 434 right or else we dissipate in to the abyss.

Anyway, I'll be quiet and wait to see how the next little bit unfolds.

Expand

Going it alone (for now) is not as easy as it sounds.

DS and team are amazing at what they do, but are they good business/finance managers? How will they manage this $40M diligently?

My guess is they needed some serious money behind them before a BP is comfortable to partner.

Looking forward to (hoping) for an announcement in the coming weeks,

ATH Price at posting: 1.2¢ Sentiment: Buy Disclosure: Held
7 Upvote

0 Great analysis

Reply

Top Stories

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

First 168 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.0¢		Change 0.001(11.1%)		Mkt cap ! $91.27M

Open	High	Low	Value	Volume
0.9¢	1.0¢	0.9¢	$41.54K	4.357M

Buyers (Bids)

No.	Vol.	Price($)
35	11136808	0.9¢

Sellers (Offers)

Price($)	Vol.	No.
1.0¢	4729475	10

View Market Depth

No.	Vol.	Price($)
33	11051808	0.009
18	11245794	0.008
16	10257963	0.007
13	8003518	0.006
6	3350001	0.005

Price($)	Vol.	No.
0.010	4726475	9
0.011	5569414	14
0.012	23020191	27
0.013	6944325	13
0.014	12788180	6

Last trade - 16.10pm 27/06/2025 (20 minute delay)

ATH (ASX) Chart

Ann: Trading Halt, page-168

Australia’s gas crisis is here – and dying coal plants aren’t helping

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Monash IVF shares cater 25% – Disaster or deep-value play?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Trading Halt, page-168

Top Stories

Australia’s gas crisis is here – and dying coal plants aren’t helping

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Monash IVF shares cater 25% – Disaster or deep-value play?

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News